AMBRX BIOPHARMA, INC. INDEMNIFICATION AGREEMENTIndemnification Agreement • September 12th, 2023 • New Ambrx Biopharma Inc. • Biological products, (no disgnostic substances) • Delaware
This Indemnification Agreement (this “Agreement”) is made as of [●], 2023, by and between Ambrx Biopharma, Inc., a Delaware corporation (the “Company”), and [ ] (the “Indemnitee”).
AGREEMENT AND PLAN OF MERGERAgreement and Plan of Merger • September 12th, 2023 • New Ambrx Biopharma Inc. • Biological products, (no disgnostic substances)
This AGREEMENT AND PLAN OF MERGER (this “Agreement”) is made and entered into as of September 11, 2023 (the “Effective Date”), by and among Ambrx Biopharma Inc., a Cayman Islands exempted company (“Ambrx”), New Ambrx Biopharma Inc., a Delaware corporation (“Parent”), and Ambrx Merger Sub Inc., a Cayman Islands exempted company and wholly-owned subsidiary of Parent (“Merger Sub”, together with Ambrx and Parent, the “Parties” and each, a “Party”).
AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • September 12th, 2023 • New Ambrx Biopharma Inc. • Biological products, (no disgnostic substances) • California
This Amended and Restated Executive Employment Agreement (“Agreement”) amends and restates in its entirety that certain Executive Employment Agreement, dated as of [DATE] (the “Previous Employment Agreement”), by and between Ambrx, Inc., a Delaware corporation (the “Company”) and [NAME] (the “Executive”), and is made effective as of [DATE], 2023 (“Effective Date”), by and between the Company and the Executive (collectively, the “Parties”, and individually, a “Party”).
